NCT06795529Recruiting
Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
Randomized Trial of a Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
Source: ClinicalTrials.gov · Last updated 18 Nov 2025
Brief summary (registry, in English)
Many people living with metastatic breast cancer face challenging symptoms and frequent medical visits. At the same time, conversations about personal goals, values, and preferences for care may not always happen as early or as often as patients and families would like. This multi-site study will test the effectiveness of a five-session palliative care program, designed specifically for people with metastatic breast cancer and their caregivers, to strengthen communication with clinicians about what matters most in their care. The study aims to inform how palliative care services can be delivered in a more timely, personalized, and scalable way for people living with advanced cancers who have long disease trajectories, such as metastatic breast cancer.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- First submitted
- 18 Jan 2025
- Start date
- 1 Oct 2025
- Primary completion date
- 1 Oct 2029
- Lead sponsor
- Massachusetts General Hospital
- Diseases
- Metastatic breast cancer
- NCT number
- NCT06795529
What you commit to
- Study type: Interventional
- Planned participants: 400
- From 1 Oct 2025 to the primary completion date, 1 Oct 2029
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- Patient Inclusion Criteria:
- age ≥18 years
- diagnosed with metastatic breast cancer
- within 8 weeks of the oncology visit at which they were identified as having an eligible Epic EOL Care Index (≥ 15)
- functioning independently per an Eastern Cooperative Oncology Group performance status ≤2
- receiving their cancer care at one of the participating institutions
- able to complete questionnaires in English or Spanish
- Patient Exclusion Criteria:
- received outpatient palliative care visit within the last six months
- enrolled in hospice services
- diagnosed with a comorbid condition that impairs their ability to understand study procedures and/or consent for the trial as per the report of the oncology clinician(s)
- Caregiver Inclusion Criteria:
- age ≥18 years
- identified by the patient as a family member or friend who is primarily involved in their care
- able to complete questionnaires in English or Spanish
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Massachusetts General Hospital Coordinator of this site? Confirm its status | Boston | United States | Recruiting |
| Duke University Coordinator of this site? Confirm its status | Durham | United States | Recruiting |
| University of Pennsylvania Coordinator of this site? Confirm its status | Philadelphia | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.